Berner Reha Zentrum
Heiligenschwendi, Canton of Bern, 3625, Switzerland
NCT Number: NCT04579055
The 1-minute sit to stand (1-min STS) test is a standardized test which is used to examine exercise capacity in patients with chronic obstructive pulmonary disease (COPD). The chair seat height used is standardized to 46-48 cm. Using a standard seat height for all patients - irrespective of their body height - may lead to invalid estimates of functional exercise capacity. The objective of this study is to assess whether there is a difference in repetitions during the 1-min STS test if the seat height is adjusted to 90° knee joint angle or the standard height chair of 46 cm is used.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Heiligenschwendi, Canton of Bern, 3625, Switzerland
In a single-center, randomized crossover study, the investigators aim to elucidate whether there is a difference in repetitions during the 1-min STS test if the seat height is adjusted to 90° knee joint angle or the standard height chair of 46 cm is used.
Patients with COPD referred for pulmonary rehabilitation will be invited to perform one standardised- (chair seat height 46cm) and one individualized (chair seat height adapted to 90° knee flexion) 1-min STS test on two different days in random order.
The tests will be performed after patients are familiarised with the 1-min STS testing procedure and learning effects can be excluded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individually adjusted chair seat height of 90° knee joint flexion
Standardized chair seat height of 46 cm
Time frame: During pulmonary rehabilitation, approximately 14 days
difference in the amount of sit to stand repetitions in the 1-min STS test from a standard chair (46cm) or an individualized seat height chair of 90° knee joint angle
Time frame: During pulmonary rehabilitation, approximately 14 days
The sit to stand power index is used to calculate the force-generating capacity (in watt) of the knee extensor muscles and is defined as: (leg length (in m) - seat height (in m)) x body mass x acceleration of gravity x sit to stand repetitions / time (sit-stand) (in sec.)
Time frame: During pulmonary rehabilitation, approximately 14 days
Difference in oxygen saturation profiles between the two experimental conditions
Time frame: During pulmonary rehabilitation, approximately 14 days
Difference in heart rate profiles between the two experimental conditions
Time frame: During pulmonary rehabilitation, approximately 14 days
Difference in perceived exertion profiles between the two experimental conditions measured with the category ratio - 10 Borg scale (0-10)
Time frame: During pulmonary rehabilitation, approximately 14 days
Difference in perceived breathlessness profiles between the two experimental conditions measured with the category ratio - 10 Borg scale (0-10)
Time frame: During pulmonary rehabilitation, approximately 14 days
The number of incorrectly performed repetitions during th 1-min STS test
Time frame: During pulmonary rehabilitation, approximately 14 days
Multiple choice questions about patient reported perception concerning sitting position, chair height, perceived difficulties during the 1-min sit to stand test.
Thomas Riegler
Other
The Impact of Chair Seat Height on the 1-Minute Sit to Stand Test Performance in Chronic Obstructive Pulmonary Disease: a Randomized Cross-over Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05572333
COPD, Chronic Disease
Frankfurt, Germany
View Trial DetailsNCT05516316
COPD, Chronic Disease
Hanover, Germany
View Trial DetailsNCT02760329
Asthma, Bronchial Diseases
Loma Linda, California, United States
View Trial DetailsNCT06474858
Body Weight, COPD
Arnhem, Netherlands
View Trial Details